Actinogen Medical funded beyond November results

By Proactive Investors / August 03, 2026 / www.youtube.com / Article Link

Actinogen Medical has kept its pivotal XanaMIA Alzheimer's disease trial on schedule for topline results in November 2026.

Recent News

Mining sector far outpaces tech over past three years

September 21, 2026 / www.canadianminingreport.com

Gold stocks down with GDXJ outperforming on rebalancing

September 21, 2026 / www.canadianminingreport.com

Copper slides as US apparently wavering on tariff hikes

September 14, 2026 / www.canadianminingreport.com

Historically huge distortion in global copper inventory balance

September 14, 2026 / www.canadianminingreport.com

Gold stocks pause along with metal price

September 07, 2026 / www.canadianminingreport.com

See all >